We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+3.35%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$2.5B
AUM Growth
+$24.1M
Cap. Flow
-$42.8M
Cap. Flow %
-1.71%
Top 10 Hldgs %
24.87%
Holding
364
New
26
Increased
93
Reduced
181
Closed
21

Top Buys

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$19.8M
2
COST icon
Costco
COST
+$8.57M
3
CSCO icon
Cisco
CSCO
+$8.47M
4
AGN
Allergan plc
AGN
+$6.25M
5
RBA icon
RB Global
RBA
+$4.25M

Sector Composition

Rank Sector Weight
1 Industrials 14.5%
2 Healthcare 13.66%
3 Technology 13%
4 Financials 12.64%
5 Consumer Staples 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEM icon
176
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$1.5M 0.06%
36,137
+4,457
+14% +$181K
ISRG icon
177
Intuitive Surgical
ISRG
$127B
$1.48M 0.06%
14,256
+225
+2% +$21.6K
QCOM icon
178
Qualcomm
QCOM
$155B
$1.47M 0.06%
26,601
+2,702
+11% +$151K
AJG icon
179
Arthur J. Gallagher & Co
AJG
$64.1B
$1.45M 0.06%
25,247
+444
+2% +$25.1K
MDT icon
180
Medtronic
MDT
$109B
$1.43M 0.06%
16,102
-49,699
-76% -$4.19M
HP icon
181
Helmerich & Payne
HP
$3.45B
$1.35M 0.05%
24,800
-114
-0.5% -$6.68K
AXGN icon
182
Axogen
AXGN
$2.27B
$1.32M 0.05%
78,905
+66,510
+537% +$897K
RDS.A
183
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.31M 0.05%
24,648
-788
-3% -$42.2K
BIIB icon
184
Biogen
BIIB
$30B
$1.25M 0.05%
4,609
-715
-13% -$189K
EWBC icon
185
East-West Bancorp
EWBC
$17.9B
$1.25M 0.05%
21,354
+927
+5% +$51K
PBA icon
186
Pembina Pipeline
PBA
$28.4B
$1.22M 0.05%
+36,675
New +$1.19M
ALK icon
187
Alaska Air
ALK
$5.29B
$1.19M 0.05%
13,306
+3,025
+29% +$265K
KTOS icon
188
Kratos Defense & Security Solutions
KTOS
$8.74B
$1.18M 0.05%
99,373
ITW icon
189
Illinois Tool Works
ITW
$82.6B
$1.18M 0.05%
8,225
-381
-4% -$53.1K
OXY icon
190
Occidental Petroleum
OXY
$56.8B
$1.18M 0.05%
19,671
+524
+3% +$32.1K
VO icon
191
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$1.16M 0.05%
32,420
+22,940
+242% +$811K
WRB icon
192
W.R. Berkley
WRB
$26.9B
$1.15M 0.05%
56,045
-820
-1% -$16.6K
ROST icon
193
Ross Stores
ROST
$80.5B
$1.11M 0.04%
19,231
-724
-4% -$45.2K
RDS.B
194
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.09M 0.04%
20,081
+871
+5% +$48.5K
BNS icon
195
Scotiabank
BNS
$107B
$1.09M 0.04%
18,120
+700
+4% +$40.1K
MHK icon
196
Mohawk Industries
MHK
$7.5B
$1.08M 0.04%
4,485
NATI
197
DELISTED
National Instruments Corp
NATI
$1.06M 0.04%
26,483
-25
-0.1% -$910
ZION icon
198
Zions Bancorporation
ZION
$10.2B
$1.06M 0.04%
24,140
+14,338
+146% +$590K
AMGN icon
199
Amgen
AMGN
$208B
$1.05M 0.04%
6,072
+591
+11% +$96.1K
PAGP icon
200
Plains GP Holdings
PAGP
$5.21B
$1.04M 0.04%
39,924
-163,177
-80% -$4.56M

Similar funds

Bradley Foster & Sargent's Q2 2017 Portfolio in Review

As of Q2 2017, Bradley Foster & Sargent held 364 positions worth $2.5B, up 0.97% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Bradley Foster & Sargent's Q2 2017 filing shows 26 new, 93 increased, 181 reduced and 21 closed positions. Its largest new stake was RB Global: 136,975 shares worth $3.94M. The largest sale was Walgreens Boots Alliance, an estimated $15.6M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

  • Bradley Foster & Sargent's largest Q2 2017 buy was RB Global: 136,975 shares worth $3.94M.
  • Bradley Foster & Sargent added most to Northrop Grumman in Q2 2017, an estimated $19.8M increase.
  • Bradley Foster & Sargent's biggest Q2 2017 reduction was Walgreens Boots Alliance, cutting an estimated $15.6M.
  • Bradley Foster & Sargent fully exited Under Armour in Q2 2017, selling an estimated $3.38M.
  • Bradley Foster & Sargent's ten largest holdings make up 25% of its $2.5B portfolio in Q2 2017.
  • Bradley Foster & Sargent opened 26 new positions and closed 21 in Q2 2017.
  • Bradley Foster & Sargent's portfolio value rose 0.97% quarter-over-quarter to $2.5B.

Based on Bradley Foster & Sargent's 13F filing for Q2 2017, filed 9 Aug 2017.